Efficacy and safefy of Polymyxin B treatment for neutropenic patients suffering from refractory Gram-negative bacterial bloodstream infection

Meng ZHOU; Hui-Zhu KANG; Cheng-Yuan GU; Yue-Jun LIU; Ying WANG; Miao MIAO; Jian-Hong FU; Xiao-Wen TANG; Hui-Ying QIU; Cheng-Cheng FU; Zheng-Ming JIN; Cai-Xia LI; Su-Ning CHEN; Ai-Ning SUN; De-Pei WU; Yue HAN.
Chinese Journal of Hematology ; (12): 484-489, 2023.
Artículo en Zh | WPRIM | ID: wpr-984648

Documentos relacionados

  1. [Efficacy and safefy of Polymyxin B treatment for neutropenic patients suffering from refractory Gram-negative bacterial bloodstream infection].
  2. Machine learning model for the prediction of gram-positive and gram-negative bacterial bloodstream infection based on routine laboratory parameters.
  3. Risk factors for positive follow-up blood cultures in Gram-negative bacteremia among immunocompromised patients with neutropenia.
  4. Is Short-Course Antibiotic Therapy Suitable for Pseudomonas aeruginosa Bloodstream Infections in Onco-hematology Patients With Febrile Neutropenia? Results of a Multi-institutional Analysis.
  5. Non-neutropenic fever in children with cancer: Management, outcomes and clinical decision rule validation.
  6. Oral fluoroquinolones for definitive treatment of gram-negative bacteremia in cancer patients.
  7. Comparison Between Peripheral and Central Blood Cultures in Pediatric Oncology Patients With Blood Stream Infections.
  8. Evaluating antimicrobial duration for Gram-negative bacteremia in patients with neutropenia due to hematologic malignancy or hematopoietic stem cell transplantation.
  9. Ethics of antibiotic allergy.
  10. Efficacy of Teicoplanin Lock Therapy in the Treatment of Port-related Coagulase-negative Staphylococci Bacteremia in Pediatric Oncology Patients.